JOURNAL OF CANCER RESEARCH AND ONCOBIOLOGY (ISSN:2517-7370)

Biography:

Robert J. Amato is a Professor in the Department of Internal Medicine and Director of the Division of Oncology at McGovern Medical School, The University of Texas Health Science Center at Houston, and the Memorial Hermann Cancer Center.

He received his D.O. from The University of North Texas in Fort Worth, Texas, in 1983. He serves as an editorial board member and reviewer for numerous journals and has had more than 300 publications over the course of his career.

Dr. Amato is one of the world’s leading experts in the treatment of genitourinary cancer. Early in his career, his research helped make testicular cancer a highly treatable disease. His current clinical research focuses on molecular-targeted therapeutics to halt the progression of metastatic kidney and prostate cancers, the further development of immunotherapies with a primary focus on vaccine and immune therapy, and the development of more effective treatments for bladder cancer. He is also involved in a number of translational research projects seeking insight into the molecular alterations associated with disease progression and resistance adaptation, as well as biomarker discovery.

Research Interests:

His research interests focuses on Tumor Immunology, Molecular Targeted Therapy, Genitourinary Oncology, Personalized Therapy, Circulating Tumor Cells, Biomarker Discovery, Next-Generation Sequencing.